Abstract
Myasthenia gravis is an autoimmune neuromuscular disease. The electromyographic pattern, a positive response to cholinesterase inhibitors, and the presence of antibodies to the acetylcholine receptor are typical findings in myasthenic patients. Other factors, including age of onset, sex, thymic disease, and HLA and Gm allotypes,1 2 3 4 5 may be of prognostic value. As in most autoimmune disorders, the cause of the disease remains unknown. In this report we describe a patient with aplastic anemia treated with bone-marrow transplantation in whom graft-versus-host disease and subsequently myasthenia gravis developed. Chromosomal studies suggested that the myasthenia was of donor origin. Acetylcholine-receptor antibodies were detected two . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
